These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 18632843)

  • 21. Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling.
    Scherner O; Meurer SK; Tihaa L; Gressner AM; Weiskirchen R
    J Biol Chem; 2007 May; 282(19):13934-43. PubMed ID: 17376778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone morphogenetic protein-7 expression and activity in the human adult normal kidney is predominantly localized to the distal nephron.
    Wetzel P; Haag J; Câmpean V; Goldschmeding R; Atalla A; Amann K; Aigner T
    Kidney Int; 2006 Aug; 70(4):717-23. PubMed ID: 16807538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BMP-7/TGF-β1 signalling in myoblasts: components involved in signalling and BMP-7-dependent blockage of TGF-β-mediated CTGF expression.
    Meurer SK; Esser M; Tihaa L; Weiskirchen R
    Eur J Cell Biol; 2012; 91(6-7):450-63. PubMed ID: 22099397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms through which bradykinin promotes glomerular injury in diabetes.
    Tan Y; Wang B; Keum JS; Jaffa AA
    Am J Physiol Renal Physiol; 2005 Mar; 288(3):F483-92. PubMed ID: 15692059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1.
    Kersten C; Sivertsen EA; Hystad ME; Forfang L; Smeland EB; Myklebust JH
    BMC Immunol; 2005 May; 6():9. PubMed ID: 15877825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BMP-7/Smads-induced inhibitor of differentiation 2 (Id2) upregulation and Id2/Twist interaction was involved in attenuating diabetic renal tubulointerstitial fibrosis.
    Xiao Y; Jiang X; Peng C; Zhang Y; Xiao Y; Liang D; Shi M; Wang Y; Zhang F; Guo B
    Int J Biochem Cell Biol; 2019 Nov; 116():105613. PubMed ID: 31539631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease.
    Burns WC; Twigg SM; Forbes JM; Pete J; Tikellis C; Thallas-Bonke V; Thomas MC; Cooper ME; Kantharidis P
    J Am Soc Nephrol; 2006 Sep; 17(9):2484-94. PubMed ID: 16914537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine.
    Twigg SM; Cao Z; MCLennan SV; Burns WC; Brammar G; Forbes JM; Cooper ME
    Endocrinology; 2002 Dec; 143(12):4907-15. PubMed ID: 12446618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells.
    Luo Q; Kang Q; Si W; Jiang W; Park JK; Peng Y; Li X; Luu HH; Luo J; Montag AG; Haydon RC; He TC
    J Biol Chem; 2004 Dec; 279(53):55958-68. PubMed ID: 15496414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway.
    Zhou G; Li C; Cai L
    Am J Pathol; 2004 Dec; 165(6):2033-43. PubMed ID: 15579446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta.
    Abreu JG; Ketpura NI; Reversade B; De Robertis EM
    Nat Cell Biol; 2002 Aug; 4(8):599-604. PubMed ID: 12134160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allelic depletion of grem1 attenuates diabetic kidney disease.
    Roxburgh SA; Kattla JJ; Curran SP; O'Meara YM; Pollock CA; Goldschmeding R; Godson C; Martin F; Brazil DP
    Diabetes; 2009 Jul; 58(7):1641-50. PubMed ID: 19401426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells.
    Qi W; Chen X; Twigg S; Polhill TS; Gilbert RE; Pollock CA
    Kidney Int; 2006 Mar; 69(6):989-95. PubMed ID: 16528248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Connective tissue growth factor and its regulation: a new element in diabetic glomerulosclerosis.
    Riser BL; Cortes P
    Ren Fail; 2001; 23(3-4):459-70. PubMed ID: 11499561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glomerular mRNAs in human type 1 diabetes: biochemical evidence for microalbuminuria as a manifestation of diabetic nephropathy.
    Adler SG; Kang SW; Feld S; Cha DR; Barba L; Striker L; Striker G; Riser BL; LaPage J; Nast CC
    Kidney Int; 2001 Dec; 60(6):2330-6. PubMed ID: 11737607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor-beta2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-beta2 by impeding CTGF expression.
    Ren S; Babelova A; Moreth K; Xin C; Eberhardt W; Doller A; Pavenstädt H; Schaefer L; Pfeilschifter J; Huwiler A
    Kidney Int; 2009 Oct; 76(8):857-67. PubMed ID: 19657322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats.
    Gojo A; Utsunomiya K; Taniguchi K; Yokota T; Ishizawa S; Kanazawa Y; Kurata H; Tajima N
    Eur J Pharmacol; 2007 Jul; 568(1-3):242-7. PubMed ID: 17511984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts.
    Nakashima A; Katagiri T; Tamura M
    J Biol Chem; 2005 Nov; 280(45):37660-8. PubMed ID: 16150699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis.
    Yokoi H; Sugawara A; Mukoyama M; Mori K; Makino H; Suganami T; Nagae T; Yahata K; Fujinaga Y; Tanaka I; Nakao K
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S134-8. PubMed ID: 11576939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.